{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T18:18:10Z","timestamp":1790965090474,"version":"4.1.0"},"reference-count":103,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaad.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1016\/j.jaad.2020.04.024","type":"journal-article","created":{"date-parts":[[2020,4,11]],"date-time":"2020-04-11T19:21:56Z","timestamp":1586632916000},"page":"563-578","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":99,"title":["Characterizing the adverse dermatologic effects of hydroxychloroquine: A systematic review"],"prefix":"10.1016","volume":"83","author":[{"given":"Ajay N.","family":"Sharma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natasha A.","family":"Mesinkovska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taraneh","family":"Paravar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaad.2020.04.024_bib1","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.jaut.2009.09.008","article-title":"Recent insights in the epidemiology of autoimmune diseases: improved prevalence estimates and understanding of clustering of diseases","volume":"33","author":"Cooper","year":"2009","journal-title":"J Autoimmun"},{"key":"10.1016\/j.jaad.2020.04.024_bib2","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.jaad.2017.09.061","article-title":"Antimalarial drug toxicities in patients with cutaneous lupus and dermatomyositis: a retrospective cohort study","volume":"78","author":"Mittal","year":"2018","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2020.04.024_bib3","first-page":"96","article-title":"Porphyria precipitated by hydroxychloroquine treatment of systemic lupus erythematosus","volume":"17","author":"Baler","year":"1976","journal-title":"Cutis"},{"key":"10.1016\/j.jaad.2020.04.024_bib4","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/0002-9343(83)91270-6","article-title":"Hydroxychloroquine sulfate in rheumatoid arthritis: long-term response rate and predictive parameters","volume":"75","author":"Bell","year":"1983","journal-title":"Am J Med"},{"issue":"Suppl 1","key":"10.1016\/j.jaad.2020.04.024_bib5","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/BF03342623","article-title":"A single-blind comparative study of auranofin and hydroxychloroquine in patients with rheumatoid arthritis","volume":"3","author":"Bird","year":"1984","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.jaad.2020.04.024_bib6","first-page":"129","article-title":"Erythema annulare centrifugum: an unusual case due to hydroxychloroquine sulfate","volume":"36","author":"Hudson","year":"1985","journal-title":"Cutis"},{"key":"10.1016\/j.jaad.2020.04.024_bib7","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/S0190-9622(85)70108-9","article-title":"Plaquenil-induced erythroderma","volume":"12","author":"Slagel","year":"1985","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2020.04.024_bib8","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1016\/S0190-9622(87)80021-X","article-title":"Pustular psoriasis associated with hydroxychloroquine","volume":"16","author":"Friedman","year":"1987","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2020.04.024_bib9","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/0002-9343(92)90183-C","article-title":"Use of antimalarial drugs for the treatment of psoriatic arthritis","volume":"93","author":"Sayers","year":"1992","journal-title":"Am J Med"},{"key":"10.1016\/j.jaad.2020.04.024_bib10","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.7326\/0003-4819-119-11-199312010-00002","article-title":"Hydroxychloroquine compared with placebo in rheumatoid arthritis: a randomized controlled trial","volume":"119","author":"Clark","year":"1993","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jaad.2020.04.024_bib11","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1002\/art.1780380325","article-title":"Bullous rash and brown urine in a systemic lupus erythematosus patient treated with hydroxychloroquine","volume":"38","author":"Kutz","year":"1995","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jaad.2020.04.024_bib12","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/S0002-9343(99)80399-4","article-title":"A randomized trial of hydroxychloroquine in early rheumatoid arthritis: the HERA study","volume":"98","author":"Esdaile","year":"1995","journal-title":"Am J Med"},{"key":"10.1016\/j.jaad.2020.04.024_bib13","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1159\/000246211","article-title":"Acute generalized exanthematous pustulosis induced by hydroxychloroquine","volume":"193","author":"Assier-Bonnet","year":"1996","journal-title":"Dermatology"},{"key":"10.1016\/j.jaad.2020.04.024_bib14","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1111\/j.1346-8138.1996.tb04031.x","article-title":"Pustular psoriasis induced by hydroxychloroquine: a case report and review of the literature","volume":"23","author":"Vine","year":"1996","journal-title":"J Dermatol"},{"key":"10.1016\/j.jaad.2020.04.024_bib15","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1002\/1529-0131(199804)41:4<744::AID-ART26>3.0.CO;2-F","article-title":"Antimalarial drug-induced aquagenic-type pruritus in patients with lupus","volume":"41","author":"Jimenez-Alonso","year":"1998","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jaad.2020.04.024_bib16","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1136\/ard.57.10.582","article-title":"Long-term effectiveness of antimalarial drugs in rheumatic diseases","volume":"57","author":"Avina-Zubieta","year":"1998","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jaad.2020.04.024_bib17","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1080\/000155599750010850","article-title":"Hydroxychloroquine-induced pruritus","volume":"79","author":"Holme","year":"1999","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.jaad.2020.04.024_bib18","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1002\/1529-0131(199902)42:2<357::AID-ANR19>3.0.CO;2-J","article-title":"Dose-loading with hydroxychloroquine improves the rate of response in early, active rheumatoid arthritis: a randomized, double-blind six-week trial with eighteen-week extension","volume":"42","author":"Furst","year":"1999","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jaad.2020.04.024_bib19","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1093\/rheumatology\/39.12.1374","article-title":"Toxicity of anti-rheumatic drugs in a randomized clinical trial of early rheumatoid arthritis","volume":"39","author":"van Jaarsveld","year":"2000","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.jaad.2020.04.024_bib20","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1046\/j.1365-2230.2001.00857-3.x","article-title":"Fatal toxic epidermal necrolysis associated with hydroxychloroquine","volume":"26","author":"Murphy","year":"2001","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.jaad.2020.04.024_bib21","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1002\/art.10278","article-title":"Clinical images: hydroxychloroquine-associated mucocutaneous hyperpigmentation","volume":"46","author":"True","year":"2002","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jaad.2020.04.024_bib22","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1001\/archderm.138.9.1231","article-title":"Adverse cutaneous reactions to hydroxychloroquine are more common in patients with dermatomyositis than in patients with cutaneous lupus erythematosus","volume":"138","author":"Pelle","year":"2002","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2020.04.024_bib23","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1093\/rheumatology\/41.4.473","article-title":"Stevens-Johnson syndrome in association with hydroxychloroquine treatment for rheumatoid arthritis","volume":"41","author":"Leckie","year":"2002","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.jaad.2020.04.024_bib24","doi-asserted-by":"crossref","first-page":"3392","DOI":"10.1002\/art.10565","article-title":"Increased cutaneous reactions to hydroxychloroquine (Plaquenil) possibly associated with formulation change: comment on the letter by Alarcon","volume":"46","author":"Salido","year":"2002","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jaad.2020.04.024_bib25","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/S0190-9622(03)02733-6","article-title":"Acute generalized exanthematous pustulosis precipitated by hydroxychloroquine","volume":"50","author":"Evans","year":"2004","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2020.04.024_bib26","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1111\/j.1365-2230.2004.01412.x","article-title":"Cutaneous hyperpigmentation during therapy with hydroxychloroquine","volume":"29","author":"Millard","year":"2004","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.jaad.2020.04.024_bib27","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1111\/j.0105-1873.2004.0301e.x","article-title":"Phototoxic and photoallergic dermatitis caused by hydroxychloroquine","volume":"50","author":"Lisi","year":"2004","journal-title":"Contact Dermatitis"},{"key":"10.1016\/j.jaad.2020.04.024_bib28","first-page":"193","article-title":"Acute pustular psoriasis complicated by leukocytoclastic vasculitis","volume":"2","author":"Welsch","year":"2003","journal-title":"J Drugs Dermatol"},{"key":"10.1016\/j.jaad.2020.04.024_bib29","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/S0301-0546(06)73537-6","article-title":"Delayed hypersensitivity to hydroxychloroquine manifested by two different types of cutaneous eruptions in the same patient","volume":"34","author":"Perez-Ezquerra","year":"2006","journal-title":"Allergol Immunopathol (Madr)"},{"key":"10.1016\/j.jaad.2020.04.024_bib30","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1111\/j.1468-3083.2006.01494.x","article-title":"Hydroxychloroquine-induced pigmentation in two patients with systemic lupus erythematosus","volume":"20","author":"Reynaert","year":"2006","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jaad.2020.04.024_bib31","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1111\/j.1365-4632.2006.03075.x","article-title":"Chloroquine\/hydroxychloroquine-induced pemphigus","volume":"45","author":"Ghaffarpour","year":"2006","journal-title":"Intl J Dermatol"},{"key":"10.1016\/j.jaad.2020.04.024_bib32","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1111\/j.1365-2133.2007.08156.x","article-title":"Risk factors for acute generalized exanthematous pustulosis (AGEP)--results of a multinational case-control study (EuroSCAR)","volume":"157","author":"Sidoroff","year":"2007","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2020.04.024_bib33","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1007\/s10067-007-0772-1","article-title":"Hydroxychloroquine-induced DRESS syndrome","volume":"27","author":"Volpe","year":"2008","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.jaad.2020.04.024_bib34","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1097\/01.rhu.0000260649.36417.09","article-title":"Cutaneous hyperpigmentation during therapy with hydroxychloroquine","volume":"13","author":"Amichai","year":"2007","journal-title":"J Clin Rheumatol"},{"key":"10.1016\/j.jaad.2020.04.024_bib35","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1016\/j.clinthera.2008.05.014","article-title":"Acute generalized exanthematous pustulosis induced by hydroxychloroquine: three cases and a review of the literature","volume":"30","author":"Paradisi","year":"2008","journal-title":"Clin Ther"},{"key":"10.1016\/j.jaad.2020.04.024_bib36","doi-asserted-by":"crossref","first-page":"18","DOI":"10.4103\/0378-6323.38401","article-title":"Comparative study of efficacy and safety of hydroxychloroquine and chloroquine in polymorphic light eruption: a randomized, double-blind, multicentric study","volume":"74","author":"Pareek","year":"2008","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"10.1016\/j.jaad.2020.04.024_bib37","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1111\/j.1365-2710.2008.00955.x","article-title":"Hydroxychloroquine-induced hyperpigmentation: a case report","volume":"33","author":"Melikoglu","year":"2008","journal-title":"J Clin Pharm Ther"},{"key":"10.1016\/j.jaad.2020.04.024_bib38","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1111\/j.1600-0560.2008.01004.x","article-title":"Hydroxychloroquine-induced hyperpigmentation: the staining pattern","volume":"35","author":"Puri","year":"2008","journal-title":"J Cutan Pathol"},{"key":"10.1016\/j.jaad.2020.04.024_bib39","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1080\/03009740701769735","article-title":"Hyperpigmentation of the skin due to hydroxychloroquine","volume":"37","author":"Rood","year":"2008","journal-title":"Scand J Rheumatol"},{"key":"10.1016\/j.jaad.2020.04.024_bib40","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1111\/j.1365-2230.2008.02704.x","article-title":"Hydroxychloroquine-associated, photo-induced toxic epidermal necrolysis","volume":"33","author":"Callaly","year":"2008","journal-title":"Clin Exp Dermatol"},{"issue":"8","key":"10.1016\/j.jaad.2020.04.024_bib41","doi-asserted-by":"crossref","first-page":"2286","DOI":"10.1002\/art.23652","article-title":"Clinical image: blonde by prescription","volume":"58","author":"Meller","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jaad.2020.04.024_bib42","doi-asserted-by":"crossref","first-page":"e757","DOI":"10.1111\/j.1365-2230.2009.03480.x","article-title":"Rapid clearing of acute generalized exanthematous pustulosis after administration of ciclosporin","volume":"34","author":"Di Lernia","year":"2009","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.jaad.2020.04.024_bib43","doi-asserted-by":"crossref","first-page":"2771","DOI":"10.1056\/NEJMcpc0900639","article-title":"Case records of the Massachusetts General Hospital. Case 20-2009\u2014a 79-year-old woman with a blistering cutaneous eruption","volume":"360","author":"Avram","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaad.2020.04.024_bib44","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1007\/s10067-009-1262-4","article-title":"Acute generalized exanthematous pustulosis and toxic epidermal necrolysis induced by hydroxychloroquine","volume":"28","author":"Lateef","year":"2009","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.jaad.2020.04.024_bib45","first-page":"15","article-title":"Persistent cutaneous hyperpigmentation due to hydroxychloroquinone one year after therapy discontinuation","volume":"15","author":"Morrison","year":"2009","journal-title":"Dermatol Online J"},{"key":"10.1016\/j.jaad.2020.04.024_bib46","doi-asserted-by":"crossref","first-page":"102","DOI":"10.5021\/ad.2010.22.1.102","article-title":"A case of hydroxychloroquine induced acute generalized exanthematous pustulosis confirmed by accidental oral provocation","volume":"22","author":"Park","year":"2010","journal-title":"Ann Dermatol"},{"key":"10.1016\/j.jaad.2020.04.024_bib47","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1111\/j.1346-8138.2012.01591.x","article-title":"Hydroxychloroquine-induced hyperpigmentation","volume":"39","author":"Cho","year":"2012","journal-title":"J Dermatol"},{"key":"10.1016\/j.jaad.2020.04.024_bib48","first-page":"532","article-title":"Treatment failure with disease-modifying antirheumatic drugs in rheumatoid arthritis patients","volume":"53","author":"Mittal","year":"2012","journal-title":"Singapore Med J"},{"key":"10.1016\/j.jaad.2020.04.024_bib49","doi-asserted-by":"crossref","first-page":"414","DOI":"10.2310\/7750.2013.12105","article-title":"Acute generalized exanthematous pustulosis induced by hydroxychloroquine: first case report in Canada and review of the literature","volume":"17","author":"Bailey","year":"2013","journal-title":"J Cutan Med Surg"},{"key":"10.1016\/j.jaad.2020.04.024_bib50","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.reuma.2013.06.004","article-title":"Generalized skin hyperpigmentation and longitudinal melanonychia secondary to treatment with hydroxychloroquine in systemic lupus erythematosus","volume":"9","author":"Sifuentes Giraldo","year":"2013","journal-title":"Reumatol Clin"},{"key":"10.1016\/j.jaad.2020.04.024_bib51","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1001\/jamadermatol.2013.709","article-title":"Hydroxychloroquine-induced pigmentation in patients with systemic lupus erythematosus: a case-control study","volume":"149","author":"Jallouli","year":"2013","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.jaad.2020.04.024_bib52","first-page":"20723","article-title":"Hydroxycholoroquine-induced hyperpigmentation","volume":"19","author":"Mir","year":"2013","journal-title":"Dermatol Online J"},{"key":"10.1016\/j.jaad.2020.04.024_bib53","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/s13555-013-0032-z","article-title":"Hydroxychloroquine-associated hyperpigmentation mimicking elder abuse","volume":"3","author":"Cohen","year":"2013","journal-title":"Dermatol Ther (Heidelb)"},{"key":"10.1016\/j.jaad.2020.04.024_bib54","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1097\/RHU.0b013e31829d547b","article-title":"Hydroxychloroquine-induced hyperpigmentation","volume":"19","author":"Tracy","year":"2013","journal-title":"J Clin Rheumatol"},{"key":"10.1016\/j.jaad.2020.04.024_bib55","article-title":"Hydroxychloroquine-induced fatal toxic epidermal necrolysis complicated by angioinvasive Rhizopus","volume":"20","author":"Cameron","year":"2014","journal-title":"Dermatol Online J"},{"key":"10.1016\/j.jaad.2020.04.024_bib56","doi-asserted-by":"crossref","first-page":"693","DOI":"10.4103\/0253-7613.169589","article-title":"Hydroxychloroquine-induced acute generalized exanthematous pustulosis with positive patch-testing","volume":"47","author":"Charfi","year":"2015","journal-title":"Indian J Pharmacol"},{"key":"10.1016\/j.jaad.2020.04.024_bib57","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1056\/NEJMicm1401196","article-title":"Images in clinical medicine. Acute generalized exanthematous pustulosis","volume":"372","author":"Zhang","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaad.2020.04.024_bib58","doi-asserted-by":"crossref","first-page":"135","DOI":"10.3899\/jrheum.140995","article-title":"Hydroxychloroquine-induced hyperpigmentation of the skin","volume":"42","author":"Sawalha","year":"2015","journal-title":"J Rheumatol"},{"key":"10.1016\/j.jaad.2020.04.024_bib59","author":"McCoy"},{"key":"10.1016\/j.jaad.2020.04.024_bib60","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1159\/000438787","article-title":"Cutaneous adverse drug reactions with antimalarials and allergological skin tests","volume":"231","author":"Soria","year":"2015","journal-title":"Dermatology"},{"key":"10.1016\/j.jaad.2020.04.024_bib61","first-page":"212","article-title":"Prolonged pustular eruption from hydroxychloroquine: an unusual case of acute generalized exanthematous pustulosis","volume":"97","author":"Pearson","year":"2016","journal-title":"Cutis"},{"key":"10.1016\/j.jaad.2020.04.024_bib62","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1177\/1358863X16650276","article-title":"Serpentine supravenous hyperpigmentation due to hydroxychloroquine","volume":"21","author":"Lau","year":"2016","journal-title":"Vasc Med"},{"key":"10.1016\/j.jaad.2020.04.024_bib63","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1590\/abd1806-4841.20175561","article-title":"Acute generalized exanthematous pustulosis induced by hydroxychloroquine: a case with atypical clinical presentation","volume":"92","author":"Duman","year":"2017","journal-title":"An Bras Dermatol"},{"key":"10.1016\/j.jaad.2020.04.024_bib64","doi-asserted-by":"crossref","first-page":"e12660","DOI":"10.1111\/dth.12660","article-title":"Cyclosporine for corticosteroid-refractory acute generalized exanthematous pustulosis due to hydroxychloroquine","volume":"31","author":"Castner","year":"2018","journal-title":"Dermatol Ther"},{"key":"10.1016\/j.jaad.2020.04.024_bib65","doi-asserted-by":"crossref","first-page":"132","DOI":"10.4103\/0253-7613.201027","article-title":"Hydroxychloroquine-induced erythroderma","volume":"49","author":"Pai","year":"2017","journal-title":"Indian J Pharmacol"},{"key":"10.1016\/j.jaad.2020.04.024_bib66","doi-asserted-by":"crossref","first-page":"220","DOI":"10.23822\/EurAnnACI.1764-1489.11","article-title":"Hydroxychloroquine in the treatment of anti-histamine refractory chronic spontaneous urticaria, randomized single-blinded placebo-controlled trial and an open label comparison study","volume":"49","author":"Boonpiyathad","year":"2017","journal-title":"Eur Ann Allergy Clin Immunol"},{"key":"10.1016\/j.jaad.2020.04.024_bib67","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1177\/0961203317700486","article-title":"Hydroxychloroquine-induced hyperpigmentation in systemic diseases: prevalence, clinical features and risk factors: a cross-sectional study of 41 cases","volume":"26","author":"Bahloul","year":"2017","journal-title":"Lupus"},{"key":"10.1016\/j.jaad.2020.04.024_bib68","doi-asserted-by":"crossref","first-page":"E212","DOI":"10.1503\/cmaj.150622","article-title":"Hydroxychloroquine-related skin discoloration","volume":"189","author":"Coulombe","year":"2017","journal-title":"CMAJ"},{"key":"10.1016\/j.jaad.2020.04.024_bib69","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1002\/art.40018","article-title":"Effects of hydroxychloroquine in patients with cutaneous lupus erythematosus: a multicenter, double-blind, randomized, parallel-group trial","volume":"69","author":"Yokogawa","year":"2017","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.jaad.2020.04.024_bib70","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.jaip.2016.08.010","article-title":"The comparative safety of multiple alternative agents in refractory chronic urticaria patients","volume":"5","author":"Seth","year":"2017","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaad.2020.04.024_bib71","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1002\/acr.23471","article-title":"Efficacy of hydroxychloroquine in hand osteoarthritis: a randomized, double-blind, placebo-controlled trial","volume":"70","author":"Lee","year":"2018","journal-title":"Arthritis Care Res"},{"key":"10.1016\/j.jaad.2020.04.024_bib72","doi-asserted-by":"crossref","first-page":"e12463","DOI":"10.1111\/dth.12463","article-title":"The role of hydroxychloroquine in the treatment of lichen planopilaris: a retrospective case series and review","volume":"30","author":"Nic Dhonncha","year":"2017","journal-title":"Dermatol Ther"},{"key":"10.1016\/j.jaad.2020.04.024_bib73","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1097\/RHU.0000000000000417","article-title":"Hydroxychloroquine-induced erythema multiforme","volume":"23","author":"Abou Assalie","year":"2017","journal-title":"J Clin Rheumatol"},{"key":"10.1016\/j.jaad.2020.04.024_bib74","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2018-227305","article-title":"Woman in grey: hydroxychloroquine-induced hyperpigmentation","volume":"11","author":"Ivo","year":"2018","journal-title":"BMJ Case Rep"},{"key":"10.1016\/j.jaad.2020.04.024_bib75","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1136\/postgradmedj-2018-136377","article-title":"Hydroxychloroquine induced cutaneous pigmentation: a unique pattern","volume":"95","author":"Thakur","year":"2019","journal-title":"Postgrad Med J"},{"key":"10.1016\/j.jaad.2020.04.024_bib76","doi-asserted-by":"crossref","first-page":"e54","DOI":"10.1016\/j.oooo.2017.10.006","article-title":"Drug-associated hyperpigmentation of the oral mucosa: report of four cases","volume":"125","author":"Tosios","year":"2018","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol"},{"key":"10.1016\/j.jaad.2020.04.024_bib77","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.4103\/0366-6999.237411","article-title":"Hydroxychloroquine-induced psoriasis-form erythroderma in a patient with systemic lupus erythematosus","volume":"131","author":"Wang","year":"2018","journal-title":"Chin Med J (Engl)"},{"key":"10.1016\/j.jaad.2020.04.024_bib78","doi-asserted-by":"crossref","first-page":"e47","DOI":"10.14309\/crj.2018.47","article-title":"Development of drug-induced inverse psoriasis in a patient with Crohn's disease","volume":"5","author":"Darwin","year":"2018","journal-title":"ACG Case Rep J"},{"key":"10.1016\/j.jaad.2020.04.024_bib79","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2018-224619","article-title":"Hydroxychloroquine-induced inverse psoriasis","volume":"12","author":"Ullah","year":"2019","journal-title":"BMJ Case Rep"},{"key":"10.1016\/j.jaad.2020.04.024_bib80","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1177\/0036933018763277","article-title":"A case of an acute cutaneous drug reaction with hydroxychloroquine","volume":"63","author":"Randhawa","year":"2018","journal-title":"Scott Med J"},{"key":"10.1016\/j.jaad.2020.04.024_bib81","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.jaad.2017.08.045","article-title":"Changing antimalarial agents after inefficacy or intolerance in patients with cutaneous lupus erythematosus: a multicenter observational study","volume":"78","author":"Chasset","year":"2018","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2020.04.024_bib82","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1177\/0961203318781008","article-title":"Treating lupus patients with antimalarials: analysis of safety profile in a single-center cohort","volume":"27","author":"Spinelli","year":"2018","journal-title":"Lupus"},{"key":"10.1016\/j.jaad.2020.04.024_bib83","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1111\/1346-8138.14512","article-title":"Therapeutic efficacy and adverse events of hydroxychloroquine administration in Japanese systemic\/cutaneous lupus erythematosus patients","volume":"45","author":"Kishi","year":"2018","journal-title":"J Dermatol"},{"key":"10.1016\/j.jaad.2020.04.024_bib84","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1111\/1346-8138.14156","article-title":"Early cutaneous eruptions after oral hydroxychloroquine in a lupus erythematosus patient: a case report and review of the published work","volume":"45","author":"Matsuda","year":"2018","journal-title":"J Dermatol"},{"issue":"3","key":"10.1016\/j.jaad.2020.04.024_bib85","doi-asserted-by":"crossref","first-page":"206","DOI":"10.5152\/eurjrheum.2018.17190","article-title":"A case of exogenous ochronosis associated with hydroxychloroquine","volume":"5","author":"Tekg\u00f6z","year":"2018","journal-title":"Eur J Rheumatol"},{"key":"10.1016\/j.jaad.2020.04.024_bib86","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1001\/jamadermatol.2018.2549","article-title":"Association between autoantibody phenotype and cutaneous adverse reactions to hydroxychloroquine in dermatomyositis","volume":"154","author":"Wolstencroft","year":"2018","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.jaad.2020.04.024_bib87","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1159\/000500406","article-title":"The first pediatric case of acute generalized exanthematous pustulosis caused by hydroxychloroquine","volume":"104","author":"Liccioli","year":"2019","journal-title":"Pharmacology"},{"key":"10.1016\/j.jaad.2020.04.024_bib88","first-page":"207","article-title":"Pustular DRESS syndrome secondary to hydroxychloroquine with EBV reactivation","volume":"18","author":"Girijala","year":"2019","journal-title":"J Drugs Dermatol"},{"key":"10.1016\/j.jaad.2020.04.024_bib89","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1016\/j.jaad.2019.01.040","article-title":"Treatment of morphea with hydroxychloroquine: a retrospective review of 84 patients at Mayo Clinic, 1996-2013","volume":"80","author":"Kumar","year":"2019","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2020.04.024_bib90","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1177\/0961203318812685","article-title":"Longitudinal melanonychia and subungual hemorrhage in a patient with systemic lupus erythematosus treated with hydroxychloroquine","volume":"28","author":"Zhang","year":"2019","journal-title":"Lupus"},{"key":"10.1016\/j.jaad.2020.04.024_bib91","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1111\/1756-185X.13387","article-title":"Effectiveness and safety of hydroxychloroquine therapy with or without corticosteroid in patients with systemic lupus erythematosus","volume":"22","author":"Miyagawa","year":"2019","journal-title":"Int J Rheum Dis"},{"key":"10.1016\/j.jaad.2020.04.024_bib92","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1177\/0961203319879987","article-title":"Simple dose-escalation regimen for hydroxychloroquine-induced hypersensitivity reaction in patients with systemic lupus erythematosus enabled treatment resumption","volume":"28","author":"Takamasu","year":"2019","journal-title":"Lupus"},{"key":"10.1016\/j.jaad.2020.04.024_bib93","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1177\/0961203319854139","article-title":"A case of generalized pustular psoriasis caused by hydroxychloroquine in a patient with systemic lupus erythematosus","volume":"28","author":"Shindo","year":"2019","journal-title":"Lupus"},{"key":"10.1016\/j.jaad.2020.04.024_bib94","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1111\/1346-8138.14802","article-title":"Varied responses to and efficacies of hydroxychloroquine treatment according to cutaneous lupus erythematosus subtypes in Japanese patients","volume":"46","author":"Ototake","year":"2019","journal-title":"J Dermatol"},{"key":"10.1016\/j.jaad.2020.04.024_bib95","first-page":"111","article-title":"Sweet's syndrome following therapy with hydroxychloroquine in a patient affected with elderly-onset primary Sjogren's syndrome","volume":"6","author":"Manzo","year":"2019","journal-title":"Medicines (Basel)"},{"key":"10.1016\/j.jaad.2020.04.024_bib96","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.jaip.2018.04.041","article-title":"Delayed hypersensitivity skin reaction to hydroxychloroquine: successful short desensitization","volume":"7","author":"Barailler","year":"2019","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaad.2020.04.024_bib97","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1177\/0961203317735185","article-title":"Hydroxychloroquine desensitization, an effective method to overcome hypersensitivity - a multicenter experience","volume":"27","author":"Tal","year":"2018","journal-title":"Lupus"},{"key":"10.1016\/j.jaad.2020.04.024_bib98","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1093\/rheumatology\/keg354","article-title":"Ethnic differences in responses to disease modifying drugs","volume":"42","author":"Helliwell","year":"2003","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.jaad.2020.04.024_bib99","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/j.jaad.2019.04.068","article-title":"Adverse cutaneous drug reactions with antimalarials in cutaneous lupus and dermatomyositis: a retrospective cohort study","volume":"81","author":"Gonzalez","year":"2019","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2020.04.024_bib100","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S1568-9972(03)00006-5","article-title":"The epidemiology of autoimmune diseases","volume":"2","author":"Cooper","year":"2003","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.jaad.2020.04.024_bib101","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1080\/14740338.2017.1269168","article-title":"Hydroxychloroquine in systemic lupus erythematosus (SLE)","volume":"16","author":"Ponticelli","year":"2017","journal-title":"Expert Opin Drug Saf"},{"key":"10.1016\/j.jaad.2020.04.024_bib102","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1046\/j.1365-4362.1997.00227.x","article-title":"The in\u00a0vitro effect of hydroxychloroquine on skin morphology and transglutaminase","volume":"36","author":"Wolf","year":"1997","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.jaad.2020.04.024_bib103","doi-asserted-by":"crossref","first-page":"249","DOI":"10.2165\/00128071-200607040-00006","article-title":"The role of antimalarials in the exacerbation of psoriasis","volume":"7","author":"Herman","year":"2006","journal-title":"Am J Clin Dermatol"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962220305648?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962220305648?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T22:57:09Z","timestamp":1759273029000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0190962220305648"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8]]},"references-count":103,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,8]]}},"alternative-id":["S0190962220305648"],"URL":"https:\/\/doi.org\/10.1016\/j.jaad.2020.04.024","relation":{},"ISSN":["0190-9622"],"issn-type":[{"value":"0190-9622","type":"print"}],"subject":[],"published":{"date-parts":[[2020,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Characterizing the adverse dermatologic effects of hydroxychloroquine: A systematic review","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2020.04.024","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 by the American Academy of Dermatology, Inc.","name":"copyright","label":"Copyright"}]}}